Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

190.94
Delayed Data
As of 4:00pm ET
 -0.24 / -0.13%
Today’s Change
184.50
Today|||52-Week Range
317.48
-38.90%
Year-to-Date
Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today
2:17pm / Zacks.com - Paid Partner Content
Weekly CEO Buys Highlights
Nov 29 / GuruFocus News - Paid Partner Content
Questions Mount at Teva Amid C-suite Change
10:09am / TheStreet.com - Paid Partner Content
Weekly CEO Buys Highlight
Nov 29 / GuruFocus News - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Top Research Reports for Alphabet, Deere & Bristol-Myers
Nov 28 / Zacks.com - Paid Partner Content
Week in Review, December 2
Dec 02 / FT.com - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter
Dec 02 / GuruFocus News - Paid Partner Content
Four traders exit Paulson & Co's London office
Nov 23 / FT.com - Paid Partner Content
Stocks Mixed as November Jobs Solidify Chances of December Rate Hike
Dec 02 / TheStreet.com - Paid Partner Content
Allergan Acquires Chase Pharma, Expands CNS Portfolio
Nov 23 / Zacks.com - Paid Partner Content
Biotechs Look Dangerous Again As Trump Rally Fades
Dec 02 / Investing Channel - Paid Partner Content
Teva's Leukemia Drug Gets EU Approval in First-Line Setting
Nov 22 / Zacks.com - Paid Partner Content
Stock Futures Hold Lower After U.S. Adds 178,000 Jobs
Dec 02 / TheStreet.com - Paid Partner Content
Allergan's Fibristal Approved in Canada for Label Expansion
Nov 22 / Zacks.com - Paid Partner Content
The Deal Economy Event Is Live
Dec 01 / TheStreet.com - Paid Partner Content
Prominent investors adjust portfolios after US election
Nov 11 / FT.com - Paid Partner Content
Valeant's talks to sell Salix unit for $10bn break down
Nov 30 / FT.com - Paid Partner Content
Markets sustain Trump-mentum; Yahoo deal in doubt; Yuan slides
Nov 10 / CNNMoney.com
Teva Is a Hold
Nov 30 / GuruFocus News - Paid Partner Content
Clinton defeat provides antidote to US drugmakers
Nov 10 / FT.com - Paid Partner Content
Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
Nov 30 / TheStreet.com - Paid Partner Content
Drug and biotech stocks soar on Trump victory
Nov 09 / CNNMoney.com
Cramer: Rally Isn't Because Trump's Coming In but Because Fed's Going Out
Nov 29 / TheStreet.com - Paid Partner Content